Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
Protein and Antibody Engineering: Suppressing Degranulation of the Mast Cells and Type I Hypersensitivity Reaction Publisher Pubmed



Rajani HF1 ; Shahidi S2 ; Gomari MM1
Authors

Source: Current Protein and Peptide Science Published:2020


Abstract

With an increase in atopic cases and owing to a significant role of mast cells in type I hypersensitivity, a therapeutic need to inhibit degranulation of mast cells has risen. Mast cells are notorious for IgE-mediated allergic response. Advancements have allowed researchers to improve clinical outcomes of already available therapies. Engineered peptides and antibodies can be easily manipulated to attain desired characteristics as per the biological environment. A number of these molecules are designed to target mast cells in order to regulate the release of histamine and other mediators, thereby controlling type I hypersensitivity response. The aim of this review paper is to highlight some of the significant molecules designed for the purpose. . © 2020 Bentham Science Publishers.
Other Related Docs
5. Efficacy and Safety of Omalizumab in Paediatric Age: An Update of Literature Data, Journal of Biological Regulators and Homeostatic Agents (2016)
8. Hypersensitivity, Encyclopedia of Infection and Immunity (2022)
11. Biomaterial-Based Delivery Platforms for Transdermal Immunotherapy, Biomedicine and Pharmacotherapy (2023)